From: Choice of antipsychotic treatment by European psychiatry trainees: are decisions based on evidence?
Olanzapine | Risperidone | Haloperidol | Quetiapine | Aripiprazole | Amisulpiride | Clozapine | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P | S | P | S | P | S | P | S | P | S | P | S | P | S | |
Efficacy most important | 155 (92.8%) | 93 (93%) | 129 (83.8%) | 118 (76.1%) | 23 (82.1%) | 15 (78.9%) | 16 (72.7%) | 14 (56%) | 10 (40%) | 32 (49.2%) | 16 (94.1%) | 16 (84.2%) | 6 (100%) | 20 (90.9%) |
Side effect profile most important | 38 (22.8%) | 25 (25%) | 39 (25.3%) | 70 (45.2%) | 6 (21.4%) | 6 (31.6%) | 13 (59.1%) | 19 (76%) | 16 (64%) | 44 (67.7%) | 4 (23.5%) | 7 (36.8%) | 0 | 3 (13.6%) |